CCR2 and B-cell chronic lymphocytic leukemia: Intracellular ROS are consistently profoundly decreased in CLL cells as a result of the p66Shc defect (4), suggesting that a ROS-dependent transcription factor(s) might be involved in the enhanced expression of CCR2, CXCR3 and CCR7 in CLL cells.